Mitigating Oxidative Stress and Anti-Angiogenic State in an In Vitro Model of Preeclampsia by HY-12, an Organofluorine Hydrazone Antioxidant is a research paper published in Current Issues in Molecular Biology (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
American Heart Association
Grant: 20AIREA35120469
American Heart Association
Grant: 1R15HD110945-01A1
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
American Heart Association
Grant: 49060
American Heart Association
Grant: 49070
NIEHS NIH HHS
Grant: R43 ES011921
Preeclampsia Foundation
Grant: 2025 Peter Joseph Pappas Research Grant Award
NICHD NIH HHS
Grant: R15 HD110945
NIAMS NIH HHS
Grant: R43 AR048731
NIH HHS
Grant: 1R15HD110945-01
Massachusetts Life Sciences Center
Grant: Women's Health Innovation Grant (Capital: 49060 and General: 49070)
Harvard University
Grant: Milton Fund 2020
NICHD NIH HHS
Grant: R21 HD115117
NIDDK NIH HHS
Grant: R43 DK097843
Fields of Study
Keywords